Pendulum: The Pioneers of Live Akkermansia
Clinically-studied, keystone strains designed to transform health through the gut microbiome.*
Reimagine the health of your patients by targeting the gut microbiome
Using cutting-edge technology and microbiome science, Pendulum was the first company in the US to market live Akkermansia muciniphila. Akkermansia supports the synthesis of health-promoting postbioitics and strengthens gut barrier integrity.*
Pendulum’s Akkermansia-containing formulations have been clinically studied and published in the British Medical Journal. Improving gut barrier function and maintaining healthy blood sugar levels with Pendulum’s strains is a foundational way to help your patients find optimal health by harnessing the power of the gut microbiome.*
Pendulum is now the #1 GI Doctor recommended Akkermansia brand product.**
Pendulum Gut Fuel
Pendulum Gut Fuel is a doctor-formulated blend of functionally diverse fibers and microbiota-accessible polyphenols designed to nourish the gut microbiome as an ecosystem. Fiber diversity supports microbial composition, cross-feeding networks, and downstream metabolite production. By delivering varied fermentable substrates to the colon, Gut Fuel fuels the production of key metabolites—including short-chain fatty acids like acetate, propionate, and butyrate—central to gut barrier integrity, immune function, and metabolic signaling.*
Get to know the products
Fullscript and Pendulum provider survey with Akkermansia 500 Pro
Will continue to recommend Akkermansia 500 Pro**
Would recommend Akkermansia 500 Pro to other health care providers**
Glucose control clinical efficacy
Pendulum conducted a double-blind, placebo-controlled nutrition study that demonstrated:
- Pendulum Glucose Control’s safety for its intended use
- Glucose control has a significant statistical and clinical impact on A1c and post-meal blood sugar spikes3
- -0.6 A1c reduction
- -32.5% post prandial glucose spike reduction
Resources for your practice
Fullscript accounts are $0/month — for everyone
Get your practice and patients up and running quickly at no cost.
*These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease.
^Based on sales data, 2022-2025
**Based on a IQVIA survey of gastroenterologists, 2025